HIM
EUCRU

HGC Investment Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

HGC Investment Management’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-79,150
Closed -$794K – 398
2022
Q3 		$794K Sell
79,150
-79,150
-50% -$794K 0.05% 242
2022
Q2 		$1.58M Buy
158,300
+79,150
+100% +$788K 0.05% 281
2022
Q1 		$781K Buy
+79,150
New +$781K 0.05% 258